Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 4, pp. 281 - 290
Summary Background Use of antiretroviral treatment for HIV-1 infection has decreased AIDS-related morbidity and mortality and prevents sexual transmission of...
Infectious Disease | MORTALITY | INFECTIOUS DISEASES | THERAPY | EVENTS | ADULTS | AIDS | HIV-1-INFECTED PATIENTS | HIV-1 | Humans | Male | Young Adult | Acquired Immunodeficiency Syndrome - immunology | Neoplasms - complications | Cardiovascular Diseases - complications | Time Factors | Liver Diseases - complications | Adult | Female | Diabetes Mellitus, Type 2 - complications | Drug Administration Schedule | AIDS-Related Opportunistic Infections - immunology | AIDS-Related Opportunistic Infections - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | CD4 Lymphocyte Count | Acquired Immunodeficiency Syndrome - drug therapy | Disease Progression | Tuberculosis, Pulmonary - diagnosis | Anti-Retroviral Agents - administration & dosage | Intention to Treat Analysis | Kidney Failure, Chronic - complications | Acquired Immunodeficiency Syndrome - complications | Antiviral agents | Mortality | Public health | Bacterial infections | Acquired immune deficiency syndrome--AIDS | Drug therapy | Human immunodeficiency virus--HIV
Infectious Disease | MORTALITY | INFECTIOUS DISEASES | THERAPY | EVENTS | ADULTS | AIDS | HIV-1-INFECTED PATIENTS | HIV-1 | Humans | Male | Young Adult | Acquired Immunodeficiency Syndrome - immunology | Neoplasms - complications | Cardiovascular Diseases - complications | Time Factors | Liver Diseases - complications | Adult | Female | Diabetes Mellitus, Type 2 - complications | Drug Administration Schedule | AIDS-Related Opportunistic Infections - immunology | AIDS-Related Opportunistic Infections - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | CD4 Lymphocyte Count | Acquired Immunodeficiency Syndrome - drug therapy | Disease Progression | Tuberculosis, Pulmonary - diagnosis | Anti-Retroviral Agents - administration & dosage | Intention to Treat Analysis | Kidney Failure, Chronic - complications | Acquired Immunodeficiency Syndrome - complications | Antiviral agents | Mortality | Public health | Bacterial infections | Acquired immune deficiency syndrome--AIDS | Drug therapy | Human immunodeficiency virus--HIV
Journal Article
PLoS medicine, ISSN 1549-1277, 2015, Volume 12, Issue 4, p. e1001810
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are essential for informing first-line antiretroviral (ARV)...
SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | RESOURCE-LIMITED SETTINGS | SUB-SAHARAN AFRICA | VIROLOGICAL FAILURE | REVERSE-TRANSCRIPTASE | TREATMENT-NAIVE INDIVIDUALS | TREATMENT PROGRAMS | OLIGONUCLEOTIDE LIGATION ASSAY | ANTIRETROVIRAL TREATMENT | META-REGRESSION | Anti-HIV Agents - pharmacology | Americas | HIV-1 - drug effects | Europe | HIV Infections - virology | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Africa | Drug Resistance, Viral | HIV Reverse Transcriptase - genetics | Phylogeny | HIV-1 - genetics | Molecular Epidemiology | Asia | Base Sequence | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Mutation | Studies | Antiretroviral drugs | HIV | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus | Drug resistance
SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | RESOURCE-LIMITED SETTINGS | SUB-SAHARAN AFRICA | VIROLOGICAL FAILURE | REVERSE-TRANSCRIPTASE | TREATMENT-NAIVE INDIVIDUALS | TREATMENT PROGRAMS | OLIGONUCLEOTIDE LIGATION ASSAY | ANTIRETROVIRAL TREATMENT | META-REGRESSION | Anti-HIV Agents - pharmacology | Americas | HIV-1 - drug effects | Europe | HIV Infections - virology | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Africa | Drug Resistance, Viral | HIV Reverse Transcriptase - genetics | Phylogeny | HIV-1 - genetics | Molecular Epidemiology | Asia | Base Sequence | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Mutation | Studies | Antiretroviral drugs | HIV | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus | Drug resistance
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 02/2013, Volume 177, Issue 3, p. 264
 The incidence of human immunodeficiency virus (HIV) is the rate at which new HIV infections occur in populations. The development of accurate, practical, and...
Human immunodeficiency virus--HIV | Biomarkers | Statistical methods | Medical statistics | Epidemiology
Human immunodeficiency virus--HIV | Biomarkers | Statistical methods | Medical statistics | Epidemiology
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 07/2013, Volume 63, p. S233
 Accurate methods for estimating HIV incidence from cross-sectional samples would have great utility in prevention research. This report describes recent...
Disease prevention | Antiretroviral drugs | Algorithms | Human immunodeficiency virus--HIV | Estimating techniques
Disease prevention | Antiretroviral drugs | Algorithms | Human immunodeficiency virus--HIV | Estimating techniques
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e70413
Background: Black men who have sex with men (MSM) in the United States (US) are affected by HIV at disproportionate rates compared to MSM of other...
MORTALITY | RISK | INFECTION | SYPHILIS | DISPARITIES | MULTIDISCIPLINARY SCIENCES | HIV Infections - prevention & control | United States - epidemiology | Sexual Behavior | Prospective Studies | HIV Infections - epidemiology | Humans | African Americans | Male | Sexually Transmitted Diseases - epidemiology | Sexually Transmitted Diseases - prevention & control | Incidence | Young Adult | Homosexuality, Male | Adolescent | Adult | Prevention | Medical research | Sexually transmitted diseases | Clinical trials | Medicine, Experimental | Comparative analysis | HIV (Viruses) | HIV infection | Health care | Homosexuality | Hazard identification | Sex | Alcohol | Infections | Multivariate analysis | Medical diagnosis | Epidemiology | Confidence intervals | Mens health | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Public health | Enrollments | Feasibility studies | Seroconversion | Disease prevention | Medicine | Studies | Pathology | Infectious diseases | Hospitals | Surveillance | Men | Quantitative psychology | Community | Circumcision | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
MORTALITY | RISK | INFECTION | SYPHILIS | DISPARITIES | MULTIDISCIPLINARY SCIENCES | HIV Infections - prevention & control | United States - epidemiology | Sexual Behavior | Prospective Studies | HIV Infections - epidemiology | Humans | African Americans | Male | Sexually Transmitted Diseases - epidemiology | Sexually Transmitted Diseases - prevention & control | Incidence | Young Adult | Homosexuality, Male | Adolescent | Adult | Prevention | Medical research | Sexually transmitted diseases | Clinical trials | Medicine, Experimental | Comparative analysis | HIV (Viruses) | HIV infection | Health care | Homosexuality | Hazard identification | Sex | Alcohol | Infections | Multivariate analysis | Medical diagnosis | Epidemiology | Confidence intervals | Mens health | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Public health | Enrollments | Feasibility studies | Seroconversion | Disease prevention | Medicine | Studies | Pathology | Infectious diseases | Hospitals | Surveillance | Men | Quantitative psychology | Community | Circumcision | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e87298
Background: American Black men who have sex with men (MSM) are disproportionately affected by HIV, but the factors associated with this concentrated epidemic...
UNITED-STATES | TRANSMISSION | METAANALYSIS | RISK-REDUCTION | DISPARITIES | MULTIDISCIPLINARY SCIENCES | PREVENTION | ANTIRETROVIRAL THERAPY | INTERVENTION | AFRICAN-AMERICAN MEN | WHITE MEN | HIV Infections - prevention & control | Multivariate Analysis | United States - epidemiology | Urban Population - statistics & numerical data | Sexual Behavior - ethnology | Homosexuality, Male - ethnology | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Social Class | Sexual Behavior - psychology | Young Adult | African Americans - statistics & numerical data | Adolescent | Adult | HIV Infections - transmission | Homosexuality, Male - psychology | Cities | HIV Infections - ethnology | African Americans - psychology | Epidemics | Sexually transmitted diseases | Homosexuality | Transgender people | Social networks | Comparative analysis | HIV (Viruses) | HIV infection | Bisexual | Socio-economic aspects | Sex | African Americans | Bisexuality | Gonorrhea | Regression analysis | Mental depression | Medical diagnosis | Disease prevention | Prevention | Acquired immune deficiency syndrome--AIDS | Correlation analysis | Syphilis | Human immunodeficiency virus--HIV | Rectum | Men | Bacteria | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
UNITED-STATES | TRANSMISSION | METAANALYSIS | RISK-REDUCTION | DISPARITIES | MULTIDISCIPLINARY SCIENCES | PREVENTION | ANTIRETROVIRAL THERAPY | INTERVENTION | AFRICAN-AMERICAN MEN | WHITE MEN | HIV Infections - prevention & control | Multivariate Analysis | United States - epidemiology | Urban Population - statistics & numerical data | Sexual Behavior - ethnology | Homosexuality, Male - ethnology | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Social Class | Sexual Behavior - psychology | Young Adult | African Americans - statistics & numerical data | Adolescent | Adult | HIV Infections - transmission | Homosexuality, Male - psychology | Cities | HIV Infections - ethnology | African Americans - psychology | Epidemics | Sexually transmitted diseases | Homosexuality | Transgender people | Social networks | Comparative analysis | HIV (Viruses) | HIV infection | Bisexual | Socio-economic aspects | Sex | African Americans | Bisexuality | Gonorrhea | Regression analysis | Mental depression | Medical diagnosis | Disease prevention | Prevention | Acquired immune deficiency syndrome--AIDS | Correlation analysis | Syphilis | Human immunodeficiency virus--HIV | Rectum | Men | Bacteria | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2005, Volume 192, Issue 1, pp. 24 - 29
Background. The HIV Network for Prevention Trials (HIVNET) 012 trial showed that NVP resistance (NVPR) emerged in some women and children after the...
Women | Polymerase chain reaction | HIV/AIDS | Antiretrovirals | Health care administration | Infectious diseases | HIV | AIDS | Infants | Genetic mutation | HIV 1 | INFECTIOUS DISEASES | TRANSMISSION | ANTIRETROVIRAL THERAPY | INTRAPARTUM | Anti-HIV Agents - pharmacology | HIV Infections - prevention & control | Drug Administration Schedule | HIV-1 - drug effects | Humans | Viral Proteins - genetics | Genotype | Infant | HIV-1 - genetics | Anti-HIV Agents - administration & dosage | Pregnancy | Nevirapine - pharmacology | Drug Resistance, Viral - genetics | Time Factors | Female | Mutation | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Highly active antiretroviral therapy | Nevirapine | Dosage and administration | Drug therapy | HIV infection | Health aspects
Women | Polymerase chain reaction | HIV/AIDS | Antiretrovirals | Health care administration | Infectious diseases | HIV | AIDS | Infants | Genetic mutation | HIV 1 | INFECTIOUS DISEASES | TRANSMISSION | ANTIRETROVIRAL THERAPY | INTRAPARTUM | Anti-HIV Agents - pharmacology | HIV Infections - prevention & control | Drug Administration Schedule | HIV-1 - drug effects | Humans | Viral Proteins - genetics | Genotype | Infant | HIV-1 - genetics | Anti-HIV Agents - administration & dosage | Pregnancy | Nevirapine - pharmacology | Drug Resistance, Viral - genetics | Time Factors | Female | Mutation | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Highly active antiretroviral therapy | Nevirapine | Dosage and administration | Drug therapy | HIV infection | Health aspects
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2014, Volume 65, Issue 4, p. 390
 Analysis of samples from Uganda using serologic HIV incidence assays reveal that individuals with subtype D infection often have weak humoral immune...
Women | Immunoassay | Enzymes | Human immunodeficiency virus--HIV | Infections
Women | Immunoassay | Enzymes | Human immunodeficiency virus--HIV | Infections
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2010, Volume 363, Issue 16, pp. 1510 - 1520
In this randomized trial in children who had perinatal HIV infection despite peripartum single-dose nevirapine use and who required antiretroviral therapy...
SINGLE-DOSE NEVIRAPINE | UGANDAN WOMEN | MEDICINE, GENERAL & INTERNAL | THERAPY | ZIDOVUDINE | HIV-1 VERTICAL TRANSMISSION | GROWTH | PREVENTION | INFECTED CHILDREN | RECEIVING NEVIRAPINE | K103N RESISTANCE MUTATION | HIV Infections - prevention & control | Humans | Child, Preschool | Infant | Male | RNA, Viral - blood | Anti-HIV Agents - administration & dosage | HIV-1 - isolation & purification | Treatment Failure | Ritonavir - therapeutic use | Female | HIV Infections - mortality | HIV Infections - transmission | Drug Therapy, Combination | Infant, Newborn | Anti-Retroviral Agents - therapeutic use | Lopinavir | Pyrimidinones - therapeutic use | Kaplan-Meier Estimate | HIV-1 - genetics | Pregnancy | Pregnancy Complications, Infectious - drug therapy | HIV Infections - drug therapy | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Usage | Nevirapine | Lamivudine | HIV infection in children | Drug therapy, Combination | Drug therapy | Health aspects | Zidovudine | Antiretroviral drugs | Disease transmission | Statistical analysis | Human immunodeficiency virus--HIV | Clinical trials | Drug dosages
SINGLE-DOSE NEVIRAPINE | UGANDAN WOMEN | MEDICINE, GENERAL & INTERNAL | THERAPY | ZIDOVUDINE | HIV-1 VERTICAL TRANSMISSION | GROWTH | PREVENTION | INFECTED CHILDREN | RECEIVING NEVIRAPINE | K103N RESISTANCE MUTATION | HIV Infections - prevention & control | Humans | Child, Preschool | Infant | Male | RNA, Viral - blood | Anti-HIV Agents - administration & dosage | HIV-1 - isolation & purification | Treatment Failure | Ritonavir - therapeutic use | Female | HIV Infections - mortality | HIV Infections - transmission | Drug Therapy, Combination | Infant, Newborn | Anti-Retroviral Agents - therapeutic use | Lopinavir | Pyrimidinones - therapeutic use | Kaplan-Meier Estimate | HIV-1 - genetics | Pregnancy | Pregnancy Complications, Infectious - drug therapy | HIV Infections - drug therapy | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Usage | Nevirapine | Lamivudine | HIV infection in children | Drug therapy, Combination | Drug therapy | Health aspects | Zidovudine | Antiretroviral drugs | Disease transmission | Statistical analysis | Human immunodeficiency virus--HIV | Clinical trials | Drug dosages
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 5/2009, Volume 199, Issue 10, pp. 1554 - 1555
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9812, pp. 221 - 228
Summary Background Nevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exposed to HIV-1 via breastfeeding reduces transmission...
Internal Medicine | MORTALITY | TO-CHILD | PROPHYLAXIS | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | ANTIRETROVIRAL DRUGS | RESOURCE-LIMITED SETTINGS | FREE SURVIVAL | ZIDOVUDINE | DOSE NEVIRAPINE | PREGNANCY | HIV-1 | HIV Infections - prevention & control | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Humans | Breast Feeding | Africa South of the Sahara | Infant | CD4 Lymphocyte Count | Pregnancy Complications, Infectious - immunology | Antiretroviral Therapy, Highly Active | Pregnancy | Young Adult | HIV Infections - immunology | Pregnancy Complications, Infectious - drug therapy | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Prevention | Disease transmission | Nevirapine | Infants | Research | Diagnosis | Drug therapy | Health aspects | HIV infection | Low income groups | Health sciences | Substance abuse treatment | Womens health | Human immunodeficiency virus--HIV | Data collection | Mothers | Drug dosages | Manuscripts | Deoxyribonucleic acid--DNA | Children & youth
Internal Medicine | MORTALITY | TO-CHILD | PROPHYLAXIS | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | ANTIRETROVIRAL DRUGS | RESOURCE-LIMITED SETTINGS | FREE SURVIVAL | ZIDOVUDINE | DOSE NEVIRAPINE | PREGNANCY | HIV-1 | HIV Infections - prevention & control | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Humans | Breast Feeding | Africa South of the Sahara | Infant | CD4 Lymphocyte Count | Pregnancy Complications, Infectious - immunology | Antiretroviral Therapy, Highly Active | Pregnancy | Young Adult | HIV Infections - immunology | Pregnancy Complications, Infectious - drug therapy | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Prevention | Disease transmission | Nevirapine | Infants | Research | Diagnosis | Drug therapy | Health aspects | HIV infection | Low income groups | Health sciences | Substance abuse treatment | Womens health | Human immunodeficiency virus--HIV | Data collection | Mothers | Drug dosages | Manuscripts | Deoxyribonucleic acid--DNA | Children & youth
Journal Article
PLOS ONE, ISSN 1932-6203, 05/2019, Volume 14, Issue 5, p. e0217501
Throughout the world, men who have sex with men (MSM) are at increased risk for HIV infection compared to heterosexual men. Little is known about awareness of...
Women | Epidemics | Sexually transmitted diseases--STD | Feasibility studies | Sex | Health risks | Population studies | Systematic review | Infections | Antiretroviral therapy | Disease prevention | Prevention | Disease transmission | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Men | Transgender persons | STD | AIDS | Sexually transmitted diseases | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Women | Epidemics | Sexually transmitted diseases--STD | Feasibility studies | Sex | Health risks | Population studies | Systematic review | Infections | Antiretroviral therapy | Disease prevention | Prevention | Disease transmission | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Men | Transgender persons | STD | AIDS | Sexually transmitted diseases | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2018, Volume 13, Issue 7, p. e0198999
Background South Africa has one of the highest rates of HIV-1 (HIV) infection world-wide, with the highest rates among young women. We analyzed the molecular...
SUBTYPE-C | TRANSMISSION | INFECTIONS | RECOMBINANT SEQUENCES | MULTIDISCIPLINARY SCIENCES | PREVENTION | PHYLODYNAMICS | EPIDEMICS | PHYLOGENETICS | PREVALENCE | TOOL | HIV Infections - blood | HIV-1 - pathogenicity | HIV Infections - epidemiology | HIV Infections - genetics | Humans | South Africa - epidemiology | Genes, pol - genetics | Phylogeny | HIV-1 - genetics | Young Adult | Molecular Epidemiology | Adolescent | Adult | Female | Analysis | Young women | Research | History | Epidemiology | HIV infection | Health aspects | Biological diversity | Health sciences | Viruses | Population studies | Infections | Genetic distance | Drug resistance | Gene sequencing | Demographics | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Genetic analysis | Phylogenetics | Pol gene | Supervision | Public health | Medical research | Young adults | Data processing | Clustering | Girls | Molecular chains | Disease prevention | Medicine | Studies | Pathology | Disease transmission | Genotyping | Surveillance | Womens health | Sampling methods | Viral infections | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
SUBTYPE-C | TRANSMISSION | INFECTIONS | RECOMBINANT SEQUENCES | MULTIDISCIPLINARY SCIENCES | PREVENTION | PHYLODYNAMICS | EPIDEMICS | PHYLOGENETICS | PREVALENCE | TOOL | HIV Infections - blood | HIV-1 - pathogenicity | HIV Infections - epidemiology | HIV Infections - genetics | Humans | South Africa - epidemiology | Genes, pol - genetics | Phylogeny | HIV-1 - genetics | Young Adult | Molecular Epidemiology | Adolescent | Adult | Female | Analysis | Young women | Research | History | Epidemiology | HIV infection | Health aspects | Biological diversity | Health sciences | Viruses | Population studies | Infections | Genetic distance | Drug resistance | Gene sequencing | Demographics | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Genetic analysis | Phylogenetics | Pol gene | Supervision | Public health | Medical research | Young adults | Data processing | Clustering | Girls | Molecular chains | Disease prevention | Medicine | Studies | Pathology | Disease transmission | Genotyping | Surveillance | Womens health | Sampling methods | Viral infections | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article